Overview
Publicis Groupe S.A. is a global leader in marketing, communication, and digital transformation, based in France. The company operates in the advertising and media industry, offering a wide array of services including creative advertising, media planning and buying, public relations, and digital marketing. Some of its key projects include creating innovative marketing campaigns for major brands like Coca-Cola, L'Oréal, and Samsung.
AI+ Ask Fintel’s AI assistant about Publicis Groupe S.A..
Thinking about good questions…
Basic Stats
The share price of Publicis Groupe S.A. as of May 28, 2024 is $115.79 / share. The market cap (or net worth) of Publicis Groupe S.A. as of September 10, 2025 is $29,042.27 MM.
The Factor Analysis chart (below right) shows a view of Publicis Groupe S.A. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 29,042.27 MM |
| EV | |
| Shares Out. | 250.82 MM |
| Earnings Date | |
| EPS (TTM) | 6.82 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-07-01 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.08 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | |
| ROE | |
| ROIC | 0.11 |
| CROIC | -0.06 |
| OCROIC | 0.15 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Publicis Groupe S.A. is $120.40. The forecasts range from a low of $89.16 to a high of $143.67. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Publicis Groupe S.A.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-12-18 | DAY BY DAY | Buy | Buy | Maintains |
| 2023-11-27 | HSBC | Buy | Buy | Maintains |
| 2023-11-22 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-11-09 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-10-17 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-10-13 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2023-10-13 | MACQUARIE RESEARCH | Neutral | Neutral | Maintains |
| 2023-08-28 | HSBC | Buy | Buy | Maintains |
| 2023-08-27 | HSBC | Buy | Buy | Maintains |
| 2023-08-14 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-08-14 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-08-13 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-08-13 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-08-07 | DAY BY DAY | Buy | Buy | Maintains |
| 2023-08-06 | DAY BY DAY | Buy | Buy | Maintains |
| 2023-07-25 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2023-07-24 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2023-07-24 | MACQUARIE RESEARCH | Neutral | Neutral | Maintains |
| 2023-07-23 | MACQUARIE RESEARCH | Neutral | Neutral | Maintains |
| 2023-07-21 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-07-20 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-07-20 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2023-07-19 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2023-05-31 | REDBURN LIMITED | Buy | Buy | Maintains |
| 2023-05-30 | REDBURN LIMITED | Buy | Buy | Maintains |
| 2023-05-29 | DAY BY DAY | Hold | Buy | Upgrade |
| 2023-05-28 | DAY BY DAY | Hold | Buy | Upgrade |
| 2023-05-22 | HSBC | Buy | Buy | Maintains |
| 2023-05-21 | HSBC | Buy | Buy | Maintains |
| 2023-04-26 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-04-25 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-04-21 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-04-21 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-04-21 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2023-04-21 | MACQUARIE RESEARCH | Outperform | Neutral | Downgrade |
| 2023-04-20 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-04-20 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-04-20 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2023-04-20 | MACQUARIE RESEARCH | Outperform | Neutral | Downgrade |
| 2023-04-17 | DAY BY DAY | Hold | Buy | Upgrade |
| 2023-04-03 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-03-31 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-03-27 | HSBC | Buy | Buy | Maintains |
| 2023-03-17 | MACQUARIE RESEARCH | Outperform | Neutral | Downgrade |
| 2023-03-08 | REDBURN LIMITED | Sell | Buy | Upgrade |
| 2023-02-07 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-02-02 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2022-12-08 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2022-12-07 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2022-11-04 | BERENBERG | Buy | Buy | Maintains |
| 2022-11-03 | BERENBERG | Buy | Buy | Maintains |
| 2022-07-22 | ODDO BHF | Buy | Buy | Maintains |
| 2022-07-21 | ODDO BHF | Buy | Buy | Maintains |
| 2022-07-04 | DAY BY DAY | Buy | Hold | Downgrade |
| 2022-07-03 | DAY BY DAY | Buy | Hold | Downgrade |
| 2022-06-22 | MACQUARIE RESEARCH | Neutral | Outperform | Upgrade |
| 2022-06-21 | MACQUARIE RESEARCH | Neutral | Outperform | Upgrade |
| 2022-06-06 | DAY BY DAY | Buy | Buy | Maintains |
| 2022-06-05 | DAY BY DAY | Buy | Buy | Maintains |
| 2021-07-24 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2021-07-23 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2021-02-22 | DAY BY DAY | Buy | Buy | Maintains |
| 2021-02-04 | MACQUARIE RESEARCH | Neutral | Neutral | Maintains |
| 2021-02-04 | REDBURN LIMITED | Sell | Sell | Maintains |
| 2021-02-03 | MACQUARIE RESEARCH | Neutral | Neutral | Maintains |
| 2024-07-23 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2024-07-19 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2024-07-18 | MACQUARIE RESEARCH | Neutral | Outperform | Upgrade |
| 2024-06-10 | DAY BY DAY | Buy | Buy | Maintains |
| 2024-05-26 | HSBC | Buy | Buy | Maintains |
| 2024-03-19 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-12-17 | DAY BY DAY | Buy | Buy | Maintains |
| 2023-11-26 | HSBC | Buy | Buy | Maintains |
| 2023-11-21 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-11-08 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-10-16 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-10-12 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2023-10-12 | MACQUARIE RESEARCH | Neutral | Neutral | Maintains |
| 2025-03-23 | HSBC | Buy | Buy | Maintains |
| 2025-02-13 | DAY BY DAY | Buy | Buy | Maintains |
| 2025-02-13 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2025-02-04 | ESN/CIC MARKET SOLUTIONS | Buy | Buy | Maintains |
| 2025-01-20 | MACQUARIE RESEARCH | Outperform | Outperform | Maintains |
| 2024-12-15 | DAY BY DAY | Buy | Buy | Maintains |
| 2024-11-28 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2024-11-24 | HSBC | Buy | Buy | Maintains |
| 2024-10-21 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2024-10-17 | MACQUARIE RESEARCH | Outperform | Outperform | Maintains |
| 2025-07-17 | ESN/CIC MARKET SOLUTIONS | Buy | Buy | Maintains |
| 2025-07-16 | HUBER RESEARCH PARTNERS | Underweight | Underweight | Maintains |
| 2025-07-13 | DAY BY DAY | Hold | Buy | Upgrade |
| 2025-06-08 | DAY BY DAY | Buy | Hold | Downgrade |
| 2025-05-25 | HSBC | Buy | Buy | Maintains |
